The cross-sectional area of the median nerve: An independent prognostic biomarker in amyotrophic lateral sclerosis
The CSAmn is an easy to assess biomarker that seems reliable and reproducible. Our data also suggest that it could act as a progression and prognostic biomarker in ALS patients. Longitudinal studies with repeated measures are warranted to confirm its usefulness in the clinical practice.
Authors
- David Hervás (ORCID: https://orcid.org/0000-0003-0635-4961)
- María Elena del Baño-Aledo (ORCID: https://orcid.org/0000-0002-0739-8918)
- T. Sevilla-Mantecón
- Juan F. Vázquez‐Costa (ORCID: https://orcid.org/0000-0002-3043-7938)
- Jacinto Javier Martínez Payá (ORCID: https://orcid.org/0000-0002-9214-812X)
- José I. Tembl-Ferrairó
- José Ríos Díaz (ORCID: https://orcid.org/0000-0002-4786-3351)
Institutions
- Universitat de València (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Centro de Investigación Biomédica en Red (ES)
- Universitat Politècnica de València (ES)
- Universidad de Murcia (ES)
- Universidad Pontificia Comillas (ES)
Publication Details
- Journal
- Neurología (English Edition)
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.nrleng.2024.07.003
- Citations
- 1
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 0.37